Our Subsidiaries

We're driven by opportunity and the transformative nature of technology. Our holdings are multi-sector. Non-chemical disinfectants. Audio therapy for tinnitus. Next generation computer memory. Therapeutic devices. Nano-scale fuel cells.

The common thread among our investments: The ability to transform leading-edge research into commercial success. But it takes more than the promise of innovation to earn a place as an Allied Minds subsidiary. Every one of our investments also has an attractive risk-return profile, a deliverable timeline and potential products that will be groundbreaking in their respective fields.

  • Allied Minds Devices

    Allied Minds Devices is focused on developing transformative technologies into commercially viable medical device products.

  • AMFI

    Developing and commercializing transformative breed technology from U.S. federal research institutions.

  • Biotectix

    Enabling the next generation of implantable electrostimulation and sensing products through the development of proprietary, high-performance, conducting polymers.

  • Broadcast Routing Fountains

    Broadcast Routing Fountains is building a novel Internet architecture that seeks to efficiently and securely leverages broadcast channels for disseminating routing information.

  • Cephalogics

    Cephalogics is developing an noninvasive, bedside brain monitor to improve outcomes in patients with neurological injury while reducing costs and hospital stays.

  • CryoXtract

    CryoXtract offers a suite of automated product solutions that allow the worldwide scientific community to access/r-access valuable frozen biosamples without exposing them to damaging freeze/thaw cycles.

  • Federated Wireless

    Developing critical enabling technologies for the next-generation of wireless communications by improving supply, demand, and delivery of spectrum for future cellular communications.

  • Foreland Technologies

    Foreland Technologies is a cyber security platform company for the discovery, incubation and commercialization of emerging technologies.

  • LuxCath

    LuxCath is developing a catheter based real-time visualization technology for use during cardiac ablation procedures.

  • Optio Labs

    Optio Labs develops transformational mobile security technologies for today’s evolving cyber operating environment.

  • Percipient Networks

    Percipient Networks produces next generation security technologies for enterprise network defense.

  • Precision Biopsy

    Precision Biopsy is developing a novel medical device platform to provide real-time optical pathology of normal tissue and to minimize unnecessary tissue coring, pathology costs, and patient anxiety.

  • ProGDerm

    ProGDerm is developing a unique biologic that represents a true, natural approach to generate subcutaneous fat to enhance the appearance of skin using the body’s own processes.

  • RF Biocidics

    RF Biocidics seeks to make food safe from insects and pathogens through a game changing process that does not use chemicals, is organic, and does not alter sensory or nutritional characteristics.

  • SciFluor

    SciFluor Life Sciences is a drug discovery and development company leveraging the transformational power of fluorine to enrich pipelines with innovative new therapeutics.

  • SiEnergy Systems

    SiEnergy Systems is developing thin film low temperature SOFC that brings efficient, and affordable clean energy systems for broad application.

  • SoundCure

    SoundCure has developed an FDA-Cleared consumer medical technology offering breakthrough, customized sound therapy and complete tinnitus care to the 10% of the adults that suffers from this often debilitating condition.

  • Spin Transfer Tech

    Commercializing a MRAM computer memory that has demonstrated superior performance over other memories and is poised to become the first universal memory technology in the $70 billion computer memory market.


Printer-Friendly List